Anti-oestrogen therapy in the treatment of desmoid tumours: A systematic review

D. Bocale, M. T. Rotelli, A. Cavallini, D. F. Altomare

Research output: Contribution to journalArticle

Abstract

Aim The treatment of desmoid tumours (DTs) is controversial. Anti-oestrogen therapy has frequently been used, but clear information of its efficacy is lacking. In this systematic review we have undertaken a comprehensive analysis to assess the effectiveness of anti-oestrogen therapy in terms of ability to induce partial or complete regression of DTs. Method A systematic review of articles published in English between January 1983 and December 2009 was carried out according to the RECIST criteria. A literature search was performed on electronic databases including: United States National Library of Medicine (MEDLINE-PubMed), Excerpta Medica (EMBASE), Cochrane Library and Google search engine. Two-hundred articles dealing with DTs were identified but only fourty-one were were selected as appropriate for the study. The chi-square test was used for statistical analysis. Results Data on 168 DTs treated with anti-oestrogen agents, alone or in combination with nonsteroidal anti-inflammatory drugs, were identified with an overall response rate of 51%. There was no difference in response according to the type of DTs or between different anti-oestrogen therapies. Combination with anti-inflammatory drugs did not improve the outcome. Toremifene was sometimes effective in cases resistant to tamoxifen. Response did not seem to be related to oestrogen receptor status. Conclusions Despite potential inaccuracies in the methodology, the results of the review indicate that anti-oestrogen therapy produces some effect in about one half of patients with DTs. Its indication compared with other treatments is discussed.

Original languageEnglish
JournalColorectal Disease
Volume13
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Aggressive Fibromatosis
Estrogens
Neoplasms
Anti-Inflammatory Agents
Therapeutics
Toremifene
National Library of Medicine (U.S.)
Search Engine
Tamoxifen
Chi-Square Distribution
PubMed
MEDLINE
Estrogen Receptors
Pharmaceutical Preparations
Libraries
Databases

Keywords

  • Anti-oestrogen therapy
  • Desmoid tumours
  • Tamoxifen
  • Toremifene

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Anti-oestrogen therapy in the treatment of desmoid tumours : A systematic review. / Bocale, D.; Rotelli, M. T.; Cavallini, A.; Altomare, D. F.

In: Colorectal Disease, Vol. 13, No. 12, 12.2011.

Research output: Contribution to journalArticle

Bocale, D. ; Rotelli, M. T. ; Cavallini, A. ; Altomare, D. F. / Anti-oestrogen therapy in the treatment of desmoid tumours : A systematic review. In: Colorectal Disease. 2011 ; Vol. 13, No. 12.
@article{6a5dbbcb68f94d7e8edcec7a0e0615d4,
title = "Anti-oestrogen therapy in the treatment of desmoid tumours: A systematic review",
abstract = "Aim The treatment of desmoid tumours (DTs) is controversial. Anti-oestrogen therapy has frequently been used, but clear information of its efficacy is lacking. In this systematic review we have undertaken a comprehensive analysis to assess the effectiveness of anti-oestrogen therapy in terms of ability to induce partial or complete regression of DTs. Method A systematic review of articles published in English between January 1983 and December 2009 was carried out according to the RECIST criteria. A literature search was performed on electronic databases including: United States National Library of Medicine (MEDLINE-PubMed), Excerpta Medica (EMBASE), Cochrane Library and Google search engine. Two-hundred articles dealing with DTs were identified but only fourty-one were were selected as appropriate for the study. The chi-square test was used for statistical analysis. Results Data on 168 DTs treated with anti-oestrogen agents, alone or in combination with nonsteroidal anti-inflammatory drugs, were identified with an overall response rate of 51{\%}. There was no difference in response according to the type of DTs or between different anti-oestrogen therapies. Combination with anti-inflammatory drugs did not improve the outcome. Toremifene was sometimes effective in cases resistant to tamoxifen. Response did not seem to be related to oestrogen receptor status. Conclusions Despite potential inaccuracies in the methodology, the results of the review indicate that anti-oestrogen therapy produces some effect in about one half of patients with DTs. Its indication compared with other treatments is discussed.",
keywords = "Anti-oestrogen therapy, Desmoid tumours, Tamoxifen, Toremifene",
author = "D. Bocale and Rotelli, {M. T.} and A. Cavallini and Altomare, {D. F.}",
year = "2011",
month = "12",
doi = "10.1111/j.1463-1318.2011.02758.x",
language = "English",
volume = "13",
journal = "Colorectal Disease",
issn = "1462-8910",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Anti-oestrogen therapy in the treatment of desmoid tumours

T2 - A systematic review

AU - Bocale, D.

AU - Rotelli, M. T.

AU - Cavallini, A.

AU - Altomare, D. F.

PY - 2011/12

Y1 - 2011/12

N2 - Aim The treatment of desmoid tumours (DTs) is controversial. Anti-oestrogen therapy has frequently been used, but clear information of its efficacy is lacking. In this systematic review we have undertaken a comprehensive analysis to assess the effectiveness of anti-oestrogen therapy in terms of ability to induce partial or complete regression of DTs. Method A systematic review of articles published in English between January 1983 and December 2009 was carried out according to the RECIST criteria. A literature search was performed on electronic databases including: United States National Library of Medicine (MEDLINE-PubMed), Excerpta Medica (EMBASE), Cochrane Library and Google search engine. Two-hundred articles dealing with DTs were identified but only fourty-one were were selected as appropriate for the study. The chi-square test was used for statistical analysis. Results Data on 168 DTs treated with anti-oestrogen agents, alone or in combination with nonsteroidal anti-inflammatory drugs, were identified with an overall response rate of 51%. There was no difference in response according to the type of DTs or between different anti-oestrogen therapies. Combination with anti-inflammatory drugs did not improve the outcome. Toremifene was sometimes effective in cases resistant to tamoxifen. Response did not seem to be related to oestrogen receptor status. Conclusions Despite potential inaccuracies in the methodology, the results of the review indicate that anti-oestrogen therapy produces some effect in about one half of patients with DTs. Its indication compared with other treatments is discussed.

AB - Aim The treatment of desmoid tumours (DTs) is controversial. Anti-oestrogen therapy has frequently been used, but clear information of its efficacy is lacking. In this systematic review we have undertaken a comprehensive analysis to assess the effectiveness of anti-oestrogen therapy in terms of ability to induce partial or complete regression of DTs. Method A systematic review of articles published in English between January 1983 and December 2009 was carried out according to the RECIST criteria. A literature search was performed on electronic databases including: United States National Library of Medicine (MEDLINE-PubMed), Excerpta Medica (EMBASE), Cochrane Library and Google search engine. Two-hundred articles dealing with DTs were identified but only fourty-one were were selected as appropriate for the study. The chi-square test was used for statistical analysis. Results Data on 168 DTs treated with anti-oestrogen agents, alone or in combination with nonsteroidal anti-inflammatory drugs, were identified with an overall response rate of 51%. There was no difference in response according to the type of DTs or between different anti-oestrogen therapies. Combination with anti-inflammatory drugs did not improve the outcome. Toremifene was sometimes effective in cases resistant to tamoxifen. Response did not seem to be related to oestrogen receptor status. Conclusions Despite potential inaccuracies in the methodology, the results of the review indicate that anti-oestrogen therapy produces some effect in about one half of patients with DTs. Its indication compared with other treatments is discussed.

KW - Anti-oestrogen therapy

KW - Desmoid tumours

KW - Tamoxifen

KW - Toremifene

UR - http://www.scopus.com/inward/record.url?scp=80755155824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755155824&partnerID=8YFLogxK

U2 - 10.1111/j.1463-1318.2011.02758.x

DO - 10.1111/j.1463-1318.2011.02758.x

M3 - Article

C2 - 21831172

AN - SCOPUS:80755155824

VL - 13

JO - Colorectal Disease

JF - Colorectal Disease

SN - 1462-8910

IS - 12

ER -